Shift Bioscience announces key appointments to advance rejuvenation therapeutics pipeline Shift Bioscience announces key appointments to advance rejuvenation therapeutics pipeline Jill Reckless (CEO, RxCelerate) appointed as Translation Advisor and Laurence Reid joins as Non-Executive Director Cellevate strengthens management team with the appointment of Dr. Christel Fenge as Chief Technology Officer Cellevate strengthens management team with the appointment of Dr. Christel Fenge as Chief Technology Officer Cellevate AB is pleased to announce the appointment of Dr. Christel Fenge as Chief Technology Officer (CTO) and member of the management team Coriolis Pharma appoints Peter Sölkner to Board of Directors to support the company’s growth ambitions Coriolis Pharma appoints Peter Sölkner to Board of Directors to support the company’s growth ambitions With this appointment, Coriolis strengthens its Board of Directors with additional global expertise from the service sector for the pharmaceutical and biotech industry Aragen appoints Dr. Manjunath Ramarao as Chief Scientific Officer and Executive Vice President; Jayadeva Sajankila as Vice President and Head Aragen appoints Dr. Manjunath Ramarao as Chief Scientific Officer and Executive Vice President; Jayadeva Sajankila as Vice President and Head As the CSO, Dr. Ramarao will provide scientific leadership, nurture scientific talent, identify new and emerging capabilities and technologies and focus on green science... Ascend Advanced Therapies appoints John Chiminski as Chair & Karen Flynn as Independent Director Ascend Advanced Therapies appoints John Chiminski as Chair & Karen Flynn as Independent Director Ascend Advanced Therapies (Ascend), a gene to GMP advanced therapy development partner, today announced the appointment of John Chiminski and Karen Flynn as non-executive... Sygnature Discovery appoints new chief commercial officer Sygnature Discovery appoints new chief commercial officer Kieron Hall joins to lead commercial strategy and drive business growth Selig Group announces planned transition of chief executive officer Selig Group announces planned transition of chief executive officer Adam Sheridan to take over as CEO from July 1st Abzena appoints Taylor Boyd as chief business officer Abzena appoints Taylor Boyd as chief business officer New CBO to lead corporate development and strategic growth initiatives Rentschler Biopharma appoints Patrick Meyer as Global Head of Business Development Rentschler Biopharma appoints Patrick Meyer as Global Head of Business Development Rentschler Biopharma SE, a leading global contract development and manufacturing organisation (CDMO) for biopharmaceuticals, announced the promotion of Patrick Meyer, Ph.D., to... Seth Benson joins Nuclera as Chief Financial Officer Seth Benson joins Nuclera as Chief Financial Officer This appointment will drive commercial growth of eProtein Discovery and support strategic expansion Thermo Fisher Scientific appoints Karen S. Lynch to its Board of Directors Thermo Fisher Scientific appoints Karen S. Lynch to its Board of Directors Alongside the 11 other board members, she will implement the company's global growth strategy Eleva appoints Martin Bauer, MD as Chief Medical Officer adding substantial clinical development expertise to the organisation Eleva appoints Martin Bauer, MD as Chief Medical Officer adding substantial clinical development expertise to the organisation This appointment reflects the growing maturity of Eleva’s proprietary pipeline, which includes Eleva’s Factor H (CPV-104) program Suj Mehta named CEO of TekniPlex Healthcare Suj Mehta named CEO of TekniPlex Healthcare Long-tenured senior executive tapped to lead one of company’s two divisions, which develops groundbreaking materials science solutions that transform patient experiences, and... Sapio Sciences expands leadership team to drive growth Sapio Sciences expands leadership team to drive growth Mike Hampton joins as Chief Commercial Officer, and new scientific office strengthens Sapio’s AI-driven lab informatics leadership Nuclera appoints William J. Kullback as Non-Executive Director Nuclera appoints William J. Kullback as Non-Executive Director Bill will bring more than 30 years of experience to the role, assisting the board in implementing the company's global commercial expansion strategy Sygnature Discovery boosts growth of its in vivo pharmacology business with appointment of new Vice President Sygnature Discovery boosts growth of its in vivo pharmacology business with appointment of new Vice President